1Advanced CRC. Meta - analysis Project . Modulation of fluorouracil by leucovonn in patients with advanced colorectal cancer : evidence in terms of response rate [ J ]. J Clin Oncol, 1992,10 : 896.
4Donillard JY, Cunningham D, Roth AD, et al. lrnoteean combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic coloreetal cancer: a multicentre randomised trial [ J ]. Lancet,2000,355 (9212) : 1372.
5Toumigand C, Andre T, Achille E, et al. Folfiri followed by FOLFOX6 or the reverse sequence in advanced coldreetal cancer: a ran dnmized GERCOR study[ J ]. J Clin Onco1,2004,22 (2):229.
6Levi F, Misset J L, Brienza S, et al. A chronopharmacologic phase Ⅱ clinical trial wit h 5 - fluorouracil , folinic acid and oxaliplatin using an ambulatory multichannel programmable pump : High antitumor effec- tiveness against metastatic colorectal cancer [ J ]. Cancer, 1992,69 (4) : 893.
7Sumpter K, Harper - wynne C, Cunningham D, et al. Oxalip latin and caplorectal chemotherapy for advanced colorectal cancer: a single institution experience[ J]. Clin Oncol( R Coil radiol) ,2003,15 (15) :221.
8Twelves C. Can capeeitabine replace 5 - FU / leucovorin in combination with oxaliplatin for treatment of advanced eoloreetal cancer [ J ]. Oncology( Williston Park ) , 2002,16 ( 14 ) : 23.
9Schippinger W, Samonigg H, Schabed - Moser R. A prospective randomised phase Ⅲ trial of adjuvant chemotherapy with 5 - fluorouracil and leucovorin in patients with stage Ⅱ colon Cancer[ J]. Br J Cancer, 2007,97(8) :1021.
10Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected Stage Ⅱ Colon Cancer [ J ]. Cochrane Database Syst Rev,2008,6(3) : CD005390.
4Cremolini C,Loupakis F,Antoniotti C,et al.FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer:updated overall survival and molecular subgroup analyses of the open- label,phase 3 TRIBE study[J].Lancet Oncol,2015,16(13):1306-1315.
5Lin JK,Tan EC,Yang MC.Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwan Residents stage III colorectal cancer patients based on quality-of-life measures(QLQ-C30 and QLQ-CR38)and a new cost assessment tool[J].Health Qual Life Outcomes,2015,13(1):61.
6Miwa M,Ura M,Nishida M,et al.Design of anoveloral fluo-ropyrimi dinecar bamate,capecitabine,which generates 5 fluo-rouracil selectively in tumors byenzymes concentrated in human liver and cancer tissue[J].Eur J Cancer,2008,9(22):1026-1027.
7Antonuzzo L,Giommoni E,Pastorelli D,et al.Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer:The OBELIX study[J].World J Gastroenterol,2015,21(23):7281-7288.
